Microbiomes Solutions Symposium Speakers

Philippe Langella

Research Director at INRAE, leading the Laboratory of Commensals and Probiotics-Host Interactions (Micalis Institute). Co-founder of Exeliom Biosciences, which is advancing EXL01 (first-in-class immunomodulator derived from F. prausnitzii), a novel macrophage-targeted immunomodulator acting on NOD2 receptors.

Céline Druart

Pharmabiotic Research Institute’s (PRI) Executive Director, expert in regulatory science for Microbiome-based Products.

Paul Cotter

Head of Food Biosciences at Teagasc, is a Principal Investigator with the large Irish Research Centres, APC Microbiome Ireland, VistaMilk, and Food for Health Ireland, and CTO/co-founder of SeqBiome, a microbiome sequencing and bioinformatics service provider.

Joël Doré

Scientific Director of MetaGenoPolis (MGP), INRAE. Expert in gut microbial ecology, intestinal phylogenomics and metagenomics. Scientific advisor at MaaT Pharma, an innovative startup developing microbiome-based therapies to restore patient microbial symbiosis in dysbiosis-related diseases.

Ingmar Claes

PhD in cell and gene technology, expertise in the field of probiotics and its molecular mechanisms and skin microbiome, Co-founder and Chief Scientific Officer (CSO) at YUN Probiotherapy.

Tomas de Wouters

Food Engineer at the ETH Zurich and PhD in microbiome biology, CEO and co-founder at PharmaBiome, expert host-microbiota interaction in the human gut.

Christophe Lacroix

Professor Emeritus at the Department of Health Sciences and Food Biotechnology at ETH Zurich and a world-leading expert in food biotechnology and the production of beneficial microbes. Founder and member of the Board of Directors and the Scientific Advisory Board of PharmaBiome AG, specializing in the isolation, functional characterization, and production of gut microbe-based products for human therapy.